Skip to main content

International Vaccine Access Center


Adolescents and others at launch of HPV vaccine in Nigeria

One Dose at a Time: Mobilizing to Eliminate Cervical Cancer in Nigeria

Nigeria introduced the single-dose HPV vaccine into its routine immunization program in October 2023.

Thumbnail for 2024 event

Watch: "Celebrating Vaccine Victories: EPI at 50"

View our webinar commemorating World Immunization Week 2024.

Mother holds child

The 2023 Pneumonia and Diarrhea Progress Report is out

The latest annual report tracks progress against leading infectious killers of children across 15 key countries.

Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

IVAC's Work

The International Vaccine Access Center accelerates equitable and sustainable access to vaccines in low- and middle-income countries by generating, synthesizing, and using evidence to inform decision making and action.

Where We Work

 IVAC works with governments and major research institutions in 38 countries. Learn more about us.

Map where IVAC has worked

What We Do: Project Highlights

Vaccine Information and Epidemiology Window (VIEW-HUB)
VIEW-hub is IVAC’s publicly accessible interactive platform to visualize real-time information on vaccine use, product type, coverage levels, impact assessments, and disease burden estimates. It can be utilized to track progress and strategize ways to accelerate and optimize vaccine implementation.

Vaccine Economics Research for Sustainability & Equity (VERSE)
VERSE will compute the economic benefits and return-on-investment of vaccines, create a standardized model for assessing, tracking, and targeting vaccine coverage inequity at the country level and for monetizing the economic losses due to inequity, and more.

More Projects

Stay Connected

Sign up for our monthly newsletter to receive the latest updates on immunization-related science, policy, and access from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.